Ownership
Private
Employees
~750
Therapeutic Areas
OtherOncologyRare Diseases
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Cell therapiesGene therapiesImmuno-oncologyRadiopharmaceuticalsGeneral clinical trial sample management and biomarker analysis (broad modality support)

LabConnect General Information

LabConnect provides global central laboratory services and functional service provider solutions to pharmaceutical, biotechnology companies, CROs, and NGOs. With over two decades of experience supporting more than 1,900 clinical studies in over ninety countries, the company specializes in complex study logistics such as immuno-oncology, cell/gene therapies, rare/orphan disease research. Their offerings include custom lab kits, advanced sample tracking/logistics systems, biorepository expansion for sample storage/kit building capacity—serving more than two hundred leading biopharma clients with involvement in over twenty FDA-approved products now on the market. They are recognized for their agility and ability to integrate complex datasets into submission-ready formats.

Contact Information

Primary Industry
Contract Research Organization
Corporate Office
Johnson City, Tennessee
United States

Drug Pipeline

No pipeline data available

For full access to LabConnect's pipeline data

Book a demo

Key Partnerships

Strategic alliances with world-leading laboratories globally; serves >200 leading biopharma clients including pharmaceutical/biotech companies and CROs.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

LabConnect Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view LabConnect's complete valuation and funding history, request access »

LabConnect Financial Metrics